GB2059770A - Treatment of glaucoma - Google Patents
Treatment of glaucoma Download PDFInfo
- Publication number
- GB2059770A GB2059770A GB8031420A GB8031420A GB2059770A GB 2059770 A GB2059770 A GB 2059770A GB 8031420 A GB8031420 A GB 8031420A GB 8031420 A GB8031420 A GB 8031420A GB 2059770 A GB2059770 A GB 2059770A
- Authority
- GB
- United Kingdom
- Prior art keywords
- composition
- salt
- atherapeutic
- phenyl
- acid addition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8039379A | 1979-10-01 | 1979-10-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB2059770A true GB2059770A (en) | 1981-04-29 |
Family
ID=22157087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8031420A Withdrawn GB2059770A (en) | 1979-10-01 | 1980-09-29 | Treatment of glaucoma |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS5651413A (sv) |
| AR (1) | AR224030A1 (sv) |
| AU (1) | AU6286980A (sv) |
| BE (1) | BE885496A (sv) |
| DE (1) | DE3037164A1 (sv) |
| DK (1) | DK413280A (sv) |
| ES (1) | ES8203223A1 (sv) |
| FI (1) | FI803123L (sv) |
| FR (1) | FR2466249A1 (sv) |
| GB (1) | GB2059770A (sv) |
| IT (1) | IT1133829B (sv) |
| LU (1) | LU82816A1 (sv) |
| NO (1) | NO802890L (sv) |
| SE (1) | SE8006844L (sv) |
| ZA (1) | ZA806085B (sv) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012021629A2 (en) | 2010-08-11 | 2012-02-16 | Philadelphia Health & Education Corporation | Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629345A (en) * | 1993-07-23 | 1997-05-13 | Vide Pharmaceuticals | Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure |
| US5965620A (en) * | 1993-07-23 | 1999-10-12 | Vide Pharmaceuticals | Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure |
-
1980
- 1980-09-29 GB GB8031420A patent/GB2059770A/en not_active Withdrawn
- 1980-09-30 DK DK413280A patent/DK413280A/da not_active Application Discontinuation
- 1980-09-30 LU LU82816A patent/LU82816A1/fr unknown
- 1980-09-30 NO NO802890A patent/NO802890L/no unknown
- 1980-09-30 SE SE8006844A patent/SE8006844L/sv not_active Application Discontinuation
- 1980-10-01 FR FR8021043A patent/FR2466249A1/fr not_active Withdrawn
- 1980-10-01 FI FI803123A patent/FI803123L/fi not_active Application Discontinuation
- 1980-10-01 ES ES496072A patent/ES8203223A1/es not_active Expired
- 1980-10-01 DE DE19803037164 patent/DE3037164A1/de not_active Withdrawn
- 1980-10-01 AU AU62869/80A patent/AU6286980A/en not_active Abandoned
- 1980-10-01 BE BE0/202308A patent/BE885496A/fr unknown
- 1980-10-01 ZA ZA00806085A patent/ZA806085B/xx unknown
- 1980-10-01 IT IT25066/80A patent/IT1133829B/it active
- 1980-10-01 JP JP13593280A patent/JPS5651413A/ja active Pending
- 1980-10-10 AR AR282727A patent/AR224030A1/es active
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012021629A2 (en) | 2010-08-11 | 2012-02-16 | Philadelphia Health & Education Corporation | Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease |
| EP2603215A4 (en) * | 2010-08-11 | 2015-08-05 | Philadelphia Health & Educatio | NEW D3 DOPAMINE RECEPTOR AGONISTS FOR THE TREATMENT OF DYSKINESIA AT MORBUS PARKINSON |
| US10543180B2 (en) | 2010-08-11 | 2020-01-28 | Drexel University | D3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease |
| US11266612B2 (en) | 2010-08-11 | 2022-03-08 | Drexel University | D3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease |
Also Published As
| Publication number | Publication date |
|---|---|
| LU82816A1 (fr) | 1981-04-17 |
| SE8006844L (sv) | 1981-04-02 |
| DK413280A (da) | 1981-04-02 |
| IT1133829B (it) | 1986-07-24 |
| FI803123A7 (sv) | 1981-04-02 |
| ZA806085B (en) | 1981-09-30 |
| ES496072A0 (es) | 1982-04-01 |
| ES8203223A1 (es) | 1982-04-01 |
| NO802890L (no) | 1981-04-02 |
| AR224030A1 (es) | 1981-10-15 |
| IT8025066A0 (it) | 1980-10-01 |
| FI803123L (fi) | 1981-04-02 |
| DE3037164A1 (de) | 1981-04-16 |
| AU6286980A (en) | 1981-04-09 |
| FR2466249A1 (fr) | 1981-04-10 |
| BE885496A (fr) | 1981-04-01 |
| JPS5651413A (en) | 1981-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4599353A (en) | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma | |
| US4454151A (en) | Use of pyrrolo pyrroles in treatment of ophthalmic diseases | |
| KR100194242B1 (ko) | 눈의 염증성 질환을 치료하기 위한 3-벤조일페닐아세트산 유도체를 함유하는 국소투여가능한 조성물 | |
| KR950004885B1 (ko) | 아세틸 d-카르니틴을 함유하는 녹내장 치료제 | |
| US4599360A (en) | Ophthalmic anti-inflammatory agents | |
| US5998467A (en) | Medicine for oculopathy | |
| US5290781A (en) | Ketaneserinol as an agent to reduce intraocular pressure | |
| JP3488456B2 (ja) | 眼圧降下剤としての２−デカルボキシル−２−アミノアルキル−プロスタグランジン | |
| US5288735A (en) | Treatment of glaucoma | |
| AU616748B2 (en) | Ophthalmic solution for intraocular pressure adjustment | |
| US5066664A (en) | 2-(hydroxy-2-alkylphenylamino)-oxazolines and thiazolines as anti-glaucoma and vasoconstrictive agents | |
| US4766151A (en) | Ethers and oxime ethers of alkylamino alcohols as medicaments and novel products, and processes for their preparation | |
| AU668024B2 (en) | Agent for prophylaxis or treatment of cataract | |
| CA2065965C (en) | Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist | |
| EP0499882A1 (en) | Pharmaceutical compositions containing N-acetyl-cysteine derivatives useful for the treatment of cataracts | |
| PL208284B1 (pl) | Pochodne benzo[g]chinoliny, kompozycje je zawierające oraz zastosowanie takich pochodnych | |
| JPH06316519A (ja) | 薬剤で誘導される瞳孔拡大を抑制し又は拡大された瞳孔を 縮小するための、一定のスルファモイル置換フェネチルア ミン誘導体の使用、及びそれに用いる局部的投与組成物 | |
| US5565434A (en) | Hexose and pentose prodrugs of ethacrynic acid | |
| GB2059770A (en) | Treatment of glaucoma | |
| EP0420606B1 (en) | Use of 2-cycloalkylamino oxazolines for reducing or maintaining intraocular pressure | |
| US3991206A (en) | Alleviation of eye inflammation by topical application of p-biphenylacetic acid | |
| US4590210A (en) | Compositions for treatment of ocular hypertension | |
| JPH02258751A (ja) | ３，４―ジヒドロキシベンゾイルオキシプロパノールアミン類のプロドラッグ | |
| US5225424A (en) | Methazolamide-derived carbonic anhydrase inhibitors | |
| US5322859A (en) | Antiglaucoma drug composition and method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |